Relay Therapeutics (RLAY) Short Interest
Nasdaq • RLAY • US75943R1023
As of Oct 21, 2026, ORTEX estimated 29.8% of free float sold short, 16.2 days to cover, cost to borrow 0.53%. Sign up for live short interest data.
Nasdaq • RLAY • US75943R1023
As of Oct 21, 2026, ORTEX estimated 29.8% of free float sold short, 16.2 days to cover, cost to borrow 0.53%. Sign up for live short interest data.
This page tracks how heavily Relay Therapeutics (Nasdaq:RLAY) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Relay Therapeutics (Nasdaq: RLAY) has a market capitalization of $3.95B. Last close $18.03 (as of 2026-11-05); 52-week range $5.95 to $21.27. ORTEX data as of 2026-10-21: short interest was 29.78% of free float, 16.2 days to cover and the average cost to borrow was 0.53%. Sign up for live short interest data.